Herzliya Medical Center offers specialised HIPEC (Hyperthermic Intraperitoneal Chemotherapy) using modern cancer-treatment technology and established surgical oncology protocols. Established in 1983, the accredited hospital is situated in Herzliya, Israel, with 120 beds, serving local and international patients.

HIPEC may be used as part of a comprehensive treatment strategy for selected abdominal and peritoneal cancers. During the procedure, surgeons first remove visible tumour deposits when feasible, followed by circulating heated chemotherapy within the abdominal cavity to treat any remaining microscopic disease. Detailed imaging, tumour assessment, and evaluation of overall fitness help determine whether HIPEC is an appropriate treatment option.